N
Nektar Therapeutics (NKTR)
NCM – Real Time Price. Currency in USD
63.65
+1.62 (2.61%)
At close: Jun 26, 2026, 4:00 PM EDT
64.00
+0.35 (0.55%)
After-hours: Jun 26, 2026, 6:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
63.65
+1.62 (2.61%)
At close: Jun 26, 2026, 4:00 PM EDT
64.00
+0.35 (0.55%)
After-hours: Jun 26, 2026, 6:10 PM EDT
No Data
There are no news for this stock.
Cash reserves $131.9M barely cover the upcoming debt maturities $143.4M
Total current assets $589.0M exceed Total current liabilities $57.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-4.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$44.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.21 | 6.05 | 10 | |
| Quick ratio | 10.21 | 5.63 | 10 | |
| Debt to Equity | 0.25 | 0.30 | 8.0 | |
| Debt to Assets | 0.19 | 1.04 | 8.0 | |
| Interest coverage | -4.82 | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 92M | 90M | 98M | 55M | 56M |
| Gross Profit | 63M | 53M | 66M | 54M | 55M |
| Operating Income | -240M | -137M | -133M | -134M | -125M |
| Net Income | -368M | -276M | -119M | -164M | -158M |
| EBITDA | -228M | -130M | -129M | -133M | -124M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -7.14 | 30.88 | 5.5 |
| Next quarter | -13.65 | -21.29 | 1.0 |
| Current year | -25.37 | 6.87 | 3.0 |
| Next year | -10.46 | -22.2 | 1.0 |
| Weighted average score | 2.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -50.18 | -24.45 | -2.24 | 31.8 | 3.3 |
| Y/Y | 3.83 | 11.75 | 49.44 | 9.66 | 6.8 |
| 3y average | -12.24 | 14.68 | 24.86 | 9.39 | 6.3 |
| 5y average | -15.94 | 11.18 | 18.17 | 4.47 | 5.3 |
| Weighted average score | 5.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |